A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

Brian P. Brennan; Ryan J. Jacoby; Alik S. Widge

doi:10.1001/jamapsychiatry.2018.0927

A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

Brian P. Brennan, Ryan J. Jacoby, Alik S. Widge

Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1088-1089
Number of pages	2
Journal	JAMA psychiatry
Volume	75
Issue number	10
DOIs	https://doi.org/10.1001/jamapsychiatry.2018.0927
State	Published - Oct 2018

Bibliographical note

Funding Information:
received research grant funding from Eli Lilly and Company, Transcept Pharmaceuticals (now Paratek Pharmaceuticals), and Biohaven Pharmaceuticals and consulting fees from Rugen Therapeutics and Nobilis Therapeutics Inc. Dr Widge has received device donations and consulting fees from Medtronic and has pending patent applications related to deep brain stimulation. No other disclosures are reported.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1001/jamapsychiatry.2018.0927

Find It

Find It at U of M Libraries

Cite this

@article{ec3c5463a53945aea5ed4c7aa820b515,

title = "A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder",

author = "Brennan, {Brian P.} and Jacoby, {Ryan J.} and Widge, {Alik S.}",

note = "Funding Information: received research grant funding from Eli Lilly and Company, Transcept Pharmaceuticals (now Paratek Pharmaceuticals), and Biohaven Pharmaceuticals and consulting fees from Rugen Therapeutics and Nobilis Therapeutics Inc. Dr Widge has received device donations and consulting fees from Medtronic and has pending patent applications related to deep brain stimulation. No other disclosures are reported.",

year = "2018",

month = oct,

doi = "10.1001/jamapsychiatry.2018.0927",

language = "English (US)",

volume = "75",

pages = "1088--1089",

journal = "JAMA psychiatry",

issn = "2168-622X",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

AU - Brennan, Brian P.

AU - Jacoby, Ryan J.

AU - Widge, Alik S.

N1 - Funding Information: received research grant funding from Eli Lilly and Company, Transcept Pharmaceuticals (now Paratek Pharmaceuticals), and Biohaven Pharmaceuticals and consulting fees from Rugen Therapeutics and Nobilis Therapeutics Inc. Dr Widge has received device donations and consulting fees from Medtronic and has pending patent applications related to deep brain stimulation. No other disclosures are reported.

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85053060733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053060733&partnerID=8YFLogxK

U2 - 10.1001/jamapsychiatry.2018.0927

DO - 10.1001/jamapsychiatry.2018.0927

M3 - Comment/debate

C2 - 30128485

AN - SCOPUS:85053060733

SN - 2168-622X

VL - 75

SP - 1088

EP - 1089

JO - JAMA psychiatry

JF - JAMA psychiatry

IS - 10

ER -

A Case of Severe Intractable Contamination-Based Obsessive-Compulsive Disorder

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this